Bolt Biotherapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BOLT and other ETFs, options, and stocks.

About BOLT

Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs. 

CEO
William P. Quinn
CEOWilliam P. Quinn
Employees
52
Employees52
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
2015
Founded2015
Employees
52
Employees52

BOLT Key Statistics

Market cap
14.30M
Market cap14.30M
Price-Earnings ratio
-0.23
Price-Earnings ratio-0.23
Dividend yield
—
Dividend yield—
Average volume
114.21K
Average volume114.21K
High today
$0.379
High today$0.379
Low today
$0.3578
Low today$0.3578
Open price
$0.375
Open price$0.375
Volume
73.79K
Volume73.79K
52 Week high
$1.34
52 Week high$1.34
52 Week low
$0.30
52 Week low$0.30
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.